Deep Brain Stimulation (DBS) for the Treatment of Parkinson's Disease

NACompletedINTERVENTIONAL
Enrollment

313

Participants

Timeline

Start Date

May 17, 2013

Primary Completion Date

December 27, 2016

Study Completion Date

December 5, 2022

Conditions
Parkinson's Disease
Interventions
DEVICE

Deep Brain Stimulation

The Vercise™ DBS system will be implanted in subjects in both study arms. Stimulation parameters will vary depending on the study arm assignment. All subjects will receive therapeutic settings at the end of the blinded period.

Trial Locations (22)

10016

NYU Medical Center, New York

12208

Albany Medical Center, Albany

15212

Allegheny Health Network, Pittsburgh

27157

Wake Forest Health Sciences, Winston-Salem

29425

Medical University of South Carolina, Charleston

30322

Emory University, Atlanta

32224

Mayo Clinic, Jacksonville, Jacksonville

32610

University of Florida Shands Hospital, Gainesville

33136

University of Miami, School of Medicine, Miami

37232

Vanderbilt University, Nashville

44195

Cleveland Clinic Foundation, Cleveland

45129

University of Cincinnati, Cincinnati

55455

University of Minnesota, Minneapolis

60611

Northwestern Memorial Hospital, Chicago

60612

Rush University Medical Center, Chicago

66160

University of Kansas Hospital, Kansas City

80113

Carepoint, PC d/b/a Blue Sky Neurology, Englewood

84132

University of Utah, Salt Lake City

85013

Muhammad Ali Parkinson Research Center and Movement Disorders Clinic, Phoenix

90048

Cedars-Sinai Medical Center, Los Angeles

94115

University of California, San Francisco, San Francisco

95825

Kaiser Permanente, Sacramento, Sacramento

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY

NCT01839396 - Deep Brain Stimulation (DBS) for the Treatment of Parkinson's Disease | Biotech Hunter | Biotech Hunter